This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer | MicrobiomeTrials
← Back to trials NCT06029270
Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer Recruiting PHASE2 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2024-07-15Est. Completion: 2029-04-30
Enrollment target: 156 participantsLocations Kaiser Permanente Dublin, Dublin, California, United States Kaiser Permanente-Fremont, Fremont, California, United States Kaiser Permanente Fresno Orchard Plaza, Fresno, California, United States Kaiser Permanente-Fresno, Fresno, California, United States Keck Medicine of USC Koreatown, Los Angeles, California, United States Los Angeles General Medical Center, Los Angeles, California, United States USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States Kaiser Permanente- Modesto MOB II, Modesto, California, United States Kaiser Permanente-Modesto, Modesto, California, United States USC Norris Oncology/Hematology-Newport Beach, Newport Beach, California, United States Kaiser Permanente-Oakland, Oakland, California, United States Stanford Cancer Institute Palo Alto, Palo Alto, California, United States Kaiser Permanente-Roseville, Roseville, California, United States Kaiser Permanente Downtown Commons, Sacramento, California, United States University of California Davis Comprehensive Cancer Center, Sacramento, California, United States Other microbiome trials you might be interested in Stage II Nasopharyngeal Carcinoma AJCC v8 Stage III Nasopharyngeal Carcinoma AJCC v8 Stage IV Nasopharyngeal Carcinoma AJCC v8
This phase II trial tests effects of nivolumab in combination with chemotherapy drugs prior to radiation therapy patient…
Birmingham, United States Est. completion Mar 31, 2027
EBV Infection Stage II Nasopharyngeal Carcinoma AJCC v7 Stage III Nasopharyngeal Carcinoma AJCC v7 Stage IVA Nasopharyngeal Carcinoma AJCC v7
Kaiser Permanente-South Sacramento, Sacramento, California, United States
Kaiser Permanente-San Francisco, San Francisco, California, United States
Kaiser Permanente-Santa Teresa-San Jose, San Jose, California, United States
Kaiser Permanente San Leandro, San Leandro, California, United States
Kaiser San Rafael-Gallinas, San Rafael, California, United States
Kaiser Permanente Medical Center - Santa Clara, Santa Clara, California, United States
Kaiser Permanente-Santa Rosa, Santa Rosa, California, United States
Kaiser Permanente-South San Francisco, South San Francisco, California, United States
Kaiser Permanente-Vallejo, Vallejo, California, United States
Kaiser Permanente-Walnut Creek, Walnut Creek, California, United States
Emory University Hospital Midtown, Atlanta, Georgia, United States
Kaiser Permanente Moanalua Medical Center, Honolulu, Hawaii, United States
Saint Alphonsus Cancer Care Center-Boise, Boise, Idaho, United States
Saint Alphonsus Cancer Care Center-Caldwell, Caldwell, Idaho, United States
Kootenai Health - Coeur d'Alene, Coeur d'Alene, Idaho, United States
Saint Alphonsus Cancer Care Center-Nampa, Nampa, Idaho, United States
Kootenai Clinic Cancer Services - Post Falls, Post Falls, Idaho, United States
Kootenai Clinic Cancer Services - Sandpoint, Sandpoint, Idaho, United States
Northwestern University, Chicago, Illinois, United States
University of Illinois, Chicago, Illinois, United States
Carle at The Riverfront, Danville, Illinois, United States
Northwestern Medicine Cancer Center Kishwaukee, DeKalb, Illinois, United States
Carle Physician Group-Effingham, Effingham, Illinois, United States
Northwestern Medicine Cancer Center Delnor, Geneva, Illinois, United States
Northwestern Medicine Glenview Outpatient Center, Glenview, Illinois, United States
Northwestern Medicine Grayslake Outpatient Center, Grayslake, Illinois, United States
Northwestern Medicine Lake Forest Hospital, Lake Forest, Illinois, United States
Carle Physician Group-Mattoon/Charleston, Mattoon, Illinois, United States
Northwestern Medicine Orland Park, Orland Park, Illinois, United States
Carle Cancer Center, Urbana, Illinois, United States
Northwestern Medicine Cancer Center Warrenville, Warrenville, Illinois, United States
UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny, Iowa, United States
Saint Anthony Regional Hospital, Carroll, Iowa, United States
UI Health Care Mission Cancer and Blood - West Des Moines Clinic, Clive, Iowa, United States
Heartland Oncology and Hematology LLP, Council Bluffs, Iowa, United States
Methodist Jennie Edmundson Hospital, Council Bluffs, Iowa, United States
Nebraska Cancer Specialists/Oncology Hematology West PC - MEJ, Council Bluffs, Iowa, United States
Iowa Methodist Medical Center, Des Moines, Iowa, United States
UI Health Care Mission Cancer and Blood - Des Moines Clinic, Des Moines, Iowa, United States
Broadlawns Medical Center, Des Moines, Iowa, United States
Mercy Medical Center - Des Moines, Des Moines, Iowa, United States
UI Health Care Mission Cancer and Blood - Laurel Clinic, Des Moines, Iowa, United States
UI Healthcare Mission Cancer and Blood - Fort Dodge, Fort Dodge, Iowa, United States
UI Health Care Mission Cancer and Blood - Waukee Clinic, Waukee, Iowa, United States
Mercy Hospital South, St Louis, Missouri, United States
Mercy Hospital Saint Louis, St Louis, Missouri, United States
Community Hospital of Anaconda, Anaconda, Montana, United States
Billings Clinic Cancer Center, Billings, Montana, United States
Bozeman Health Deaconess Hospital, Bozeman, Montana, United States
Benefis Sletten Cancer Institute, Great Falls, Montana, United States
Logan Health Medical Center, Kalispell, Montana, United States
Community Medical Center, Missoula, Montana, United States
Nebraska Cancer Specialists/Oncology Hematology West PC - MECC, Omaha, Nebraska, United States
Nebraska Methodist Hospital, Omaha, Nebraska, United States
Oncology Associates PC, Omaha, Nebraska, United States
University of Cincinnati Cancer Center-UC Medical Center, Cincinnati, Ohio, United States
University of Cincinnati Cancer Center-West Chester, West Chester, Ohio, United States
University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States
Oklahoma Cancer Specialists and Research Institute-Tulsa, Tulsa, Oklahoma, United States
Saint Alphonsus Cancer Care Center-Ontario, Ontario, Oregon, United States
Providence Portland Medical Center, Portland, Oregon, United States
Providence Saint Vincent Medical Center, Portland, Oregon, United States
Medical University of South Carolina, Charleston, South Carolina, United States
Swedish Medical Center-First Hill, Seattle, Washington, United States
ProHealth D N Greenwald Center, Mukwonago, Wisconsin, United States
ProHealth Oconomowoc Memorial Hospital, Oconomowoc, Wisconsin, United States
ProHealth Waukesha Memorial Hospital, Waukesha, Wisconsin, United States
UW Cancer Center at ProHealth Care, Waukesha, Wisconsin, United States
Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
University Health Network-Princess Margaret Hospital, Toronto, Ontario, Canada
Chinese University of Hong Kong-Prince of Wales Hospital, Shatin, Hong Kong
National University Hospital Singapore, Singapore, Singapore
National Cancer Centre Singapore, Singapore, Singapore Stage IVB Nasopharyngeal Carcinoma AJCC v7
There are two study questions we are asking in this randomized phase II/III trial based on a blood biomarker, Epstein Ba…
Birmingham, United States Est. completion Dec 1, 2026